Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-64.96	17.54	50.05
Graham Fair Price	42.97	3.78	2.64
PEG	-63.84	0.29	-0.81
Price/Book	10.89	2.32	2.09
Price/Cash Flow	-45.70	50.43	92.87
Prices/Earnings	-45.50	32.68	59.96
Price/Sales	-45.50	4.23	7.75
Price/FCF	-45.70	50.43	92.87
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-3.66	0.68	0.71
Operating Margin	10.07	0.16	0.14
ROA	103.48	< 0.005	< 0.005
ROE	< 0.005	0.02	103.48
ROIC	0.02	0.06	202.97
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.02	< 0.005	408.13
Dividends QOQ	-0.38	< 0.005	-99.02
EBIT QOQ	-0.37	1.24	232.10
EPS QOQ	-0.74	1.12	50.73
FCF QOQ	3.11	1.04	-66.62
Revenue QOQ	-0.50	1.03	106.45
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	525.09	236.99	-54.87
Days Sales Outstanding (DSO)	67.72	41.89	-38.14
Inventory Turnover	0.17	0.38	121.57
Debt/Capitalization	0.37	0.36	-1.88
Quick Ratio	0.60	0.72	20.13
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	5.96	5.98	0.23
Cash	0.35	0.35	0.23
Capex	-0.15	-0.30	-101.84
Free Cash Flow	0.13	0.27	104.70
Revenue	1.61	3.28	103.94
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.77	1.77	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	10.01	3.28	-67.24
Naive Interpretation	Member

06 - Financial Health · Weak

Rating